Effect of (R)-(-)-Linalool on endothelial damage: Sex differences

Area of Science:

• Endothelial biology
• Oxidative stress and inflammation
• Pharmacology of natural compounds

Background:

• Endothelial damage, driven by oxidative stress and inflammation, exhibits sex differences.
• Lipopolysaccharide (LPS) is a key inflammatory stimulus causing endothelial dysfunction.
• (R)-(-)-Linalool (LIN) is a phytochemical with potential therapeutic benefits for endothelial health.

Purpose of the Study:

• To evaluate the protective effects of LIN against LPS-induced damage in human umbilical vein endothelial cells (HUVECs).
• To investigate potential sex differences in HUVECs' response to LPS and LIN treatment.
• To assess LIN's impact on cell viability, cytokine release, and oxidative stress markers.

Main Methods:

• Exposure of female and male HUVECs (FHUVECs and MHUVECs) to LPS and LIN.
• Measurement of cell viability, IL-6, TNF-α, malondialdehyde (MDA), and nitrite levels.
• Comparative analysis of treatment effects between sexes.

Main Results:

• LPS reduced cell viability in both FHUVECs and MHUVECs.
• LPS increased IL-6, TNF-α, and MDA in FHUVECs, while decreasing nitrites in MHUVECs.
• LIN mitigated LPS-induced damage and restored viability, with a more pronounced effect on inhibiting IL-6 and reducing MDA in FHUVECs.

Conclusions:

• Sex differences exist in HUVEC responses to LPS-induced inflammation.
• LIN demonstrates protective effects against endothelial injury, with a potentially greater impact on female cells.
• Further research is warranted to explore the sex-specific therapeutic potential of LIN in vascular endothelial injury.